TY - JOUR T1 - The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre JO - Seizure PY - 2020/07/01 AU - Davies P AU - Reuber M AU - Grunewald R AU - Howell S AU - Dickson J AU - Dennis G AU - Shanmugarajah P AU - Tsironis T AU - Brockington A ED - DO - DOI: 10.1016/j.seizure.2020.03.015 PB - Elsevier BV VL - 79 SP - 8 EP - 13 Y2 - 2025/05/05 ER -